See more : Alligator Bioscience AB (publ) (ATORX.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Banyan Corp. (BNYN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Banyan Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- REC Silicon ASA (RECSI.OL) Income Statement Analysis – Financial Results
- United Polyfab Gujarat Limited (UNITEDPOLY.NS) Income Statement Analysis – Financial Results
- Seplat Energy Plc (SEPL.L) Income Statement Analysis – Financial Results
- Jenoptik AG (JEN.SW) Income Statement Analysis – Financial Results
- FTAC Emerald Acquisition Corp. (EMLDW) Income Statement Analysis – Financial Results
Banyan Corp. (BNYN)
Industry: Medical - Care Facilities
Sector: Healthcare
About Banyan Corp.
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
| Metric | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.00M | 5.45M | 1.09M | 465.73K | 1.75M | 798.13K | 409.43K | 511.91K | 141.18K |
| Cost of Revenue | 0.00 | 53.93K | 265.65K | 106.55K | 1.09M | 339.68K | 175.08K | 244.58K | 52.57K |
| Gross Profit | 5.00M | 5.40M | 825.14K | 359.18K | 664.16K | 458.45K | 234.35K | 267.33K | 88.61K |
| Gross Profit Ratio | 100.00% | 99.01% | 75.65% | 77.12% | 37.89% | 57.44% | 57.24% | 52.22% | 62.77% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.55M | 6.97M | 3.35M | 2.57M | 4.41M | 1.29M | 1.05M | 1.44M | 665.71K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.60M | 5.75M | 3.35M | 2.57M | 4.47M | 1.29M | 1.05M | 1.61M | 665.71K |
| Cost & Expenses | 6.60M | 5.80M | 3.61M | 2.67M | 5.56M | 1.63M | 1.22M | 1.85M | 718.28K |
| Interest Income | 21.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.27M | 2.20M | 1.88M | 79.68K | 116.74K | 61.35K | 48.97K | 36.94K | 0.00 |
| Depreciation & Amortization | 2.18M | 2.18M | 2.09M | 300.62K | 206.63K | 105.79K | 41.03K | 64.50K | 22.79K |
| EBITDA | 583.94K | 1.38M | -428.39K | -1.91M | -3.31M | -728.58K | -770.87K | -1.28M | -554.31K |
| EBITDA Ratio | 21.32% | 33.52% | -16.35% | -409.46% | -202.17% | -86.65% | -151.46% | -66.99% | -308.82% |
| Operating Income | -1.59M | -351.33K | -2.52M | -2.21M | -3.80M | -834.37K | -811.90K | -1.34M | -577.10K |
| Operating Income Ratio | -31.85% | -6.45% | -231.18% | -474.01% | -216.92% | -104.54% | -198.30% | -262.19% | -408.78% |
| Total Other Income/Expenses | -482.80K | 0.00 | -250.00K | -436.91K | -487.47K | -37.03K | -150.74K | -934.74K | 38.21K |
| Income Before Tax | -2.08M | 0.00 | -2.77M | 0.00 | -3.85M | -871.40K | -962.64K | -2.28M | -538.89K |
| Income Before Tax Ratio | -41.50% | 0.00% | -254.10% | 0.00% | -219.89% | -109.18% | -235.12% | -444.78% | -381.71% |
| Income Tax Expense | 3.89M | 3.73M | 2.12M | 252.32K | 116.74K | -369.04K | 158.51K | 897.51K | -38.21K |
| Net Income | -5.48M | -4.08M | -4.65M | -2.46M | -3.92M | -465.33K | -970.41K | -2.24M | -538.89K |
| Net Income Ratio | -109.58% | -74.91% | -425.91% | -528.19% | -223.58% | -58.30% | -237.02% | -437.51% | -381.71% |
| EPS | -17.79 | -176.05 | -494.08 | -430.43 | -804.63 | -257.23 | -826.58 | -2.18K | -452.85 |
| EPS Diluted | -17.79 | -176.05 | -494.08 | -430.43 | -804.63 | -257.23 | -826.58 | -2.18K | -452.85 |
| Weighted Avg Shares Out | 308.13K | 23.19K | 9.40K | 5.72K | 4.87K | 1.81K | 1.17K | 1.03K | 1.19K |
| Weighted Avg Shares Out (Dil) | 308.13K | 23.19K | 9.40K | 5.72K | 4.87K | 1.81K | 1.17K | 1.03K | 1.19K |
Source: https://incomestatements.info
Category: Stock Reports